Investigating Surprise Signals in the Anterior Insula
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05997758 |
|
Recruitment Status :
Recruiting
First Posted : August 18, 2023
Last Update Posted : May 8, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The investigators propose a behavioral experiment with SEEG recording and stimulation, to both confirm the role of a brain region known as the anterior insula in identifying surprise, and disambiguate between competing principles behind adaptation: optimizing and satisficing. Optimizers continue to learn and adapt if performance can be improved, while satisficers are satisfied with a good enough performance and will cease adapting once that is reached.
To study surprise signals in the anterior insula, a brain structure where these signals have been very prominent, the investigators will employ an experiment with subjects who are under SEEG (stereoelectroencephalogram) recording, that is, recording from electrodes which have been surgically implanted in the brain. These recordings will be done as patients perform a task where they try to anticipate the movements of a target on a line in two different learning environments (conditions). The experimenters will then determine whether these signals reflect surprise relative to past engagement with the environment, or surprise that reveals that the agent no longer feels in control because uncertainty is not in line with the reference model. If evidence is consistent with the former, adaptation reflects traditional reinforcement and aims at optimizing behavior. If evidence instead is consistent with the latter, behavior is guided by a prior model (a reference model) and behavior is satisficing.
An fMRI study by d'Acremont and Bossaerts provides initial evidence that activation in the anterior insula supports the satisficing hypothesis, however it lacks the temporal granularity to completely rule out optimizing. In the current project, the investigators propose to use the higher time resolution of SEEG recordings to confirm these findings and reject the optimizing hypothesis.
Additionally, stimulations of the anterior insula during a subset of trials will be used to determine whether insular activation following surprise signals and preceding changes in behavior (learning) is merely correlational or in fact causal. Stimulation will allow us to determine to what extent the subjects' sense of control and subsequent behavior can be influenced in accordance with surprise-based modeling of behavior.
The cohort for this study will be patients with drug-resistant, focal epilepsy and who are hospitalized at the Hôpitaux Universitaires de Genève (HUG) for pre-surgical evaluation of their epilepsy using SEEG. The protocol will run in parallel with the patients' clinical procedures.
| Condition or disease | Intervention/treatment |
|---|---|
| Drug Resistant Epilepsy Healthy | Other: SEEG stimulation Behavioral: Adaptation task |
| Study Type : | Observational |
| Estimated Enrollment : | 50 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Cross-Sectional |
| Official Title: | Investigating Surprise Signals in the Anterior Insula in Epilepsy Patients With Stereoelectroencephalography Recording |
| Actual Study Start Date : | January 15, 2024 |
| Estimated Primary Completion Date : | July 2025 |
| Estimated Study Completion Date : | December 2025 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Patients
Patients who suffer from potentially surgically remediable drug-resistant focal epilepsy and who require evaluation with intracranial stereo-EEG electrodes and have them implanted in the anterior insula. N = 10 |
Other: SEEG stimulation
Electrodes already implanted in patient's anterior insula will be stimulated below the patient-specific threshold at which a seizure was induced. This stimulations will coincide with certain trials in the adaptation task. Behavioral: Adaptation task Participants will perform a task that requires them to learn and correctly respond to outliers of two sorts; inconsequential outliers, which require no action, and outliers that are relevant to the course of stimuli and outcomes in future trials, requiring adaptive action. |
|
Subclinical
Healthy individuals who match the clinical population in age and level of education. N = 40 |
Behavioral: Adaptation task
Participants will perform a task that requires them to learn and correctly respond to outliers of two sorts; inconsequential outliers, which require no action, and outliers that are relevant to the course of stimuli and outcomes in future trials, requiring adaptive action. |
- Bias adjustment -- non-stimulation trials (behavioral, numerical) [ Time Frame: Up to 2500 ms after stimuli presentation. All data collected during eight 5-minute sessions on the same day ]Subjects' choices, measured as the degree of bias correction they employ (a numerical value typically between 0 and +/-3) during outlier trials and the trials immediately following them. These will be quantitatively compared between conditions using Bayes-optimal choices and choices as predicted by Model-Reference Based Adaptive Control.
- Bias adjustment -- stimulation trials (behavioral, numerical) [ Time Frame: Up to 2500 ms after stimuli presentation. All data collected during four 5-minute sessions on the same day ]Subjects' choices, measured as the degree of bias correction they employ (a numerical value typically between 0 and +/-3) during stimulation trials (both outlier and non-outlier trials). These will be quantitatively compared to choices on the same trial types without stimulation.
- SEEG-ERP--non-stimulation trials [ Time Frame: Up to 2500 ms after stimuli presentation. Averaged over all trials for each task condition. All data collected during 8 5-minute sessions on the same day ]Event-related potentials (ERPs) extracted from subjects' stereoelectroencephalographies from intercranial electrodes implanted in the anterior insulae. ERPs will be averaged across the time series and t-statistics will be computed for effect of condition (outlier type).
- SEEG-TF--non-stimulation trials [ Time Frame: Up to 2500 ms after stimuli presentation. Averaged over all trials for each task condition. All data collected during 8 5-minute sessions on the same day ]The stereoelectroencephalographies from intercranial electrodes implanted in subjects' anterior insulae will be used for time frequency (TF) analyses. Time series components will be extracted for multiple frequencies and t-statistics of the effects of condition (outlier type) will be computed for each frequency.
- Reaction time (numerical) [ Time Frame: Up to 2500 ms after stimuli presentation. All data collected during 8 5-minute sessions on the same day ]Comparison of subjects' response times to stimuli
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- 18 years or older
- Fluent in French or English
- Patient who suffers from potentially surgically remediable drug-resistant focal epilepsy
- Patient who requires evaluation with intracranial stereo-EEG electrodes and has them implanted in the anterior insula
- Patient who is able and willing to provide informed consent
Exclusion Criteria:
- Severe concomitant psychiatric disease or major psychological distress
- Patients who have an implanted stimulation device (e.g. pacemaker, defibrillator, neurostimulator)
- Intellectual/neurological/psychiatric deficiencies* or inability to understand or follow the procedure
- Visual/motor deficiencies which could affect task performance
- The presence of seizures during routine clinical stimulation of insular electrodes
-
Failure to complete the pre-experiment task training
- As determined by their clinical evaluation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05997758
| Contact: Fabienne Picard, MD | +41 22 372 5258 | Fabienne.Picard@hcuge.ch | |
| Contact: Nina Sooter | +41 79 6791 949 | nina.sooter@unige.ch |
| Switzerland | |
| Service de Neurologie, Dpt des Neurosciences cliniques HUG | Recruiting |
| Geneva, Switzerland, 1205 | |
| Contact: Fabienne Picard, MD +41 22.3725.258 Fabienne.Picard@hcuge.ch | |
| Responsible Party: | Fabienne PICARD, Prof, University Hospital, Geneva |
| ClinicalTrials.gov Identifier: | NCT05997758 |
| Other Study ID Numbers: |
2022-02041 |
| First Posted: | August 18, 2023 Key Record Dates |
| Last Update Posted: | May 8, 2024 |
| Last Verified: | May 2024 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Epilepsy Drug Resistant Epilepsy Brain Diseases Central Nervous System Diseases Nervous System Diseases |